Evaluation of Antidiabetic Drug Selection and Dosage Appropriateness in Hospitalized Type 2 Diabetes Mellitus Patients at RSU Royal Prima Medan. January-June 2024
Main Article Content
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that requires appropriate drug management to achieve optimal blood glucose control. Appropriateness of drug and dose is essential to ensure the effectiveness of therapy. while cost-effectiveness analysis is needed to assess the efficiency of resource use in its management. This study aims to assess the appropriateness of the use of drugs and doses of type 2 antidiabetics based on PERKENI 2021 clinical guidelines and analyze the cost-effectiveness of therapy in hospitalized patients. This study used a retrospective descriptive method with a cross-sectional approach. The research was conducted in January-February 2025 using purposive sampling technique.The result of the 43 patients. the majority were female (55.8%) and aged 56-65 years (48.8%). The suitability of drug use in accordance with PERKENI 2021 reached 100%. but there was a dose discrepancy of 1.36%. namely the drug sitagliptin. Based on ACER and ICER parameters. the most cost-effective monotherapy is Glimepirid with an effectiveness value of 100%. an ACER value of IDR 83.886.43. while the most cost-effective combination therapy is Pioglitazon + metformin with an effectiveness value of 100%. an ACER value of IDR 100.639.21 and an ICER value of IDR 76.734.39 and IDR 13.317.37. Most of the therapies are in accordance with the PERKENI 2021 guidelines. but dosage accuracy still needs to be improved.
Article Details
References
Bastaki, S. Diabetes mellitus and its treatment. Int. J. Diabetes Metab. 13, 111–134 (2005).
Nasution, P. R., Sitepu, N. B. & Hilda, S. Antidiabetic Effect Test of Ethanol Extract of Cep Cepan Leaf (Saurauia cauliflora Dc.) in Male Mouse (Mus musculus) Streptozotocin Induced. Contag. Sci. Period. J. Public Health Coast. Health 6, 432–439 (2024).
Nuralifah, N., Parawansah, P. & Trisetya, M. Histopatologi organ pankreas tikus DM tipe 2 yang diberi ekstrak etanol daun gedi merah (Abelmoscus manihot L. Medik). J. Syifa Sci. Clin. Res. JSSCR 4, (2022).
Ninia, K. E., Oktavilantika, D. M. & Wijayanti, R. Evaluasi Penggunaan Antidiabetes Pada Pasien Diabetes Melitus Tipe 2 Rawat Inap Di Rumah Sakit Bhayangkara Brimob. J. Farm. Dan Farmakoinformatika 3, 52–65 (2024).
Rahayu, S. 2. Indonesia Cancer and Diabetes Diseases. Non–Communicable Dis. NCDs Asia Afr. 4.
Federation, I. IDF Diabetes Atlas Eighth edition 2017. International Diabetes Federation. IDF Diabetes Atlas 2017 (2021).
Venkatesh, J. S. A Prospective Study On The Assessment Of Prescribing Pattern Of Antihypertensive Drug Therapy Based On JNC VIII Guidelines In A Tertiary Care Teaching Hospital, Davangere. (2022).
Andriansyah, Y., Neswita, E. & Razoki, R. Administrative, Pharmaceutic And Clinical Study Of Prescription Anti-Diabetes Drugs In One Of Medan City Pharmacies. Jambura J. Health Sci. Res. 4, 740–747 (2022).
Bambha, K. & Kim, W. R. Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls. Eur. J. Gastroenterol. Hepatol. 16, 519–526 (2004).
Rusli, R., Nurisyah, N., Rianti, A. E. & Khafifah, K. Kesesuaian Penggunaan Obat Pada Pasien Diabetes Melitus Berdasarkan Algoritma Terapi Di Wilayah Kerja Puskesmas Andalas Dan Puskesmas Tarakan Kota Makassar. J. Media Anal. Kesehat. 15, 112–123 (2024).
Abduh, M., Alawiyah, T., Apriansyah, G., Sirodj, R. A. & Afgani, M. W. Survey Design: Cross Sectional dalam Penelitian Kualitatif. J. Pendidik. Sains Dan Komput. 3, 31–39 (2023).
Indonesia, P. E. Pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Pb Perkeni 6, (2015).
Siregar, B., Suripto, B., Hapsoro, D., Lo, E. W. & Sugiyono, F. Metode Penelitian Kombinasi (Mix Methods). Bdg. Alf. (2015).
Asamoah, J. K. K. et al. Optimal control and cost-effectiveness analysis for dengue fever model with asymptomatic and partial immune individuals. Results Phys. 31, 104919 (2021).
Yuan, F., Bangdiwala, S. I., Tong, W. & Lamy, A. The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices. Expert Rev. Pharmacoecon. Outcomes Res. 23, 69–78 (2023).
Wulandari, A., Luthfiyanti, N. & Kusumaningtyas, S. A. Evaluasi Ketepatan Pemilihan Obat dan Outcome Terapi Pada Pasien Diabetes Melitus Tipe II Rawat Jalan Di RSUD Dr. Moewardi Surakarta. PREPOTIF J. Kesehat. Masy. 8, 3733–3748 (2024).
Anders, H.-J., Peired, A. J. & Romagnani, P. SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease,‘diabetic nephropathy’, IgA nephropathy and podocytopathies with FSGS lesions. Nephrol. Dial. Transplant. 37, 1609–1615 (2022).
Natalia, A., Karolina, H., Meutia, R. & Lubis, A. A. Effectiveness of Kersen Leaf (Muntingia Calabura L.) Extract on Rats as an anti-Diabetic Agent. in 1st International Conference on Lifestyle Diseases and Natural Medicine (ICOLIFEMED 2024) 283–294 (Atlantis Press, 2025).
Sari, H., Kaban, V. E., Situmorang, F. R. & Fahdi, F. UJI EFEKTIVITAS ANTIDIABETES KOMBINASI EKSTRAK DAUN MENIRAN (Phyllanthus niruri L.) Dan KELOPAK BUNGA ROSELLA (Hibiscus sabdariffa L.) PADA TIKUS JANTAN PUTIH. J. Penelit. Farm. Herb. 2, 24–28 (2019).
Setyarna, H., Maulina, D. & Lakoan, M. R. Pola peresepan insulin pada pasien diabetes melitus tipe 2 di poli penyakit dalam BPJS rumah sakit X periode Juni–Agustus 2023. Indones. J. Health Sci. 4, 659–665 (2024).
Piragine, E., Petri, D., Martelli, A., Calderone, V. & Lucenteforte, E. Adherence to oral antidiabetic drugs in patients with type 2 diabetes: systematic review and meta-analysis. J. Clin. Med. 12, 1981 (2023).
Obakiro, S. B. et al. Appropriateness and affordability of prescriptions to diabetic patients attending a tertiary hospital in Eastern Uganda: a retrospective cross-sectional study. PloS One 16, e0245036 (2021).
Pambagyanik, A. A., Lorensia, A. & Rahem, A. Analisis Cost-Effectiveness Kombinasi Glimepiride-Metformin Dengan Glimepiride-Pioglitazone pada Pasien Diabetes Mellitus Tipe 2 Rawat Jalan. MPI Media Pharm. Indones. 5, 107–116 (2023).
Furman, B. L. Streptozotocin‐Induced Diabetic Models in Mice and Rats. Curr. Protoc. Pharmacol. 70, (2015).
Alaofi, A. L. Sinapic acid ameliorates the progression of streptozotocin (STZ)-induced diabetic nephropathy in rats via NRF2/HO-1 mediated pathways. Front. Pharmacol. 11, 1119 (2020).
Jannah, E. N., Ismunandar, A. & Maulana, L. H. Analisis Efektivitas Biaya Penggunaan Antidiabetik Oral Pada Pasien Diabetes Mellitus Tipe 2 Rawat Jalan Peserta BPJS DI RSUD BUMIAYU 2020: Array. Pharm. Perad. J. 1, 20–29 (2021).